Cargando…

Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth

OBJECTIVE: To determine if maternal plasma CRH and preterm birth history were associated with recurrent preterm birth risk in a high-risk cohort. STUDY DESIGN: Secondary analysis of pregnant women with a prior preterm birth ≤35 weeks receiving 17-alpha hydroxyprogesterone caproate for the prevention...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, Christina L., Bowman, Maria E., McIntire, Donald D., Nelson, David B., Smith, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445461/
https://www.ncbi.nlm.nih.gov/pubmed/34529698
http://dx.doi.org/10.1371/journal.pone.0257422
_version_ 1784568664161255424
author Herrera, Christina L.
Bowman, Maria E.
McIntire, Donald D.
Nelson, David B.
Smith, Roger
author_facet Herrera, Christina L.
Bowman, Maria E.
McIntire, Donald D.
Nelson, David B.
Smith, Roger
author_sort Herrera, Christina L.
collection PubMed
description OBJECTIVE: To determine if maternal plasma CRH and preterm birth history were associated with recurrent preterm birth risk in a high-risk cohort. STUDY DESIGN: Secondary analysis of pregnant women with a prior preterm birth ≤35 weeks receiving 17-alpha hydroxyprogesterone caproate for the prevention of recurrent spontaneous preterm birth. All women with a 24-week blood sample were included. Maternal plasma CRH level at 24- and 32-weeks’ gestation was measured using both enzyme-linked immunosorbent assay (ELISA) and extracted radioimmunoassay (RIA) technologies. The primary outcome was spontaneous preterm birth <37 weeks. The association of CRH, prior preterm birth history, and the two combined was assessed in relation to recurrent preterm birth risk. RESULTS: Recurrent preterm birth in this cohort of 169 women was 24.9%. Comparing women who subsequently delivered <37 versus ≥37 weeks, mean levels of CRH measured by RIA were significantly different at 24 weeks (111.1±87.5 vs. 66.1±45.4 pg/mL, P = .002) and 32 weeks (440.9±275.6 vs. 280.2±214.5 pg/mL, P = .003). The area under the receiver operating curve (AUC) at 24 and 32 weeks for (1) CRH level was 0.68 (95% CI 0.59–0.78) and 0.70 (95% CI 0.59–0.81), (2) prior preterm birth history was 0.75 (95% CI 0.67–0.83) and 0.78 (95% CI 0.69–0.87), and (3) combined was 0.81 (95% CI 0.73–0.88, P = .001) and 0.81 (95% CI 0.72–0.90, P = .01) respectively for delivery <37 weeks. CRH measured by ELISA failed to correlate with gestational age or other clinical parameters. CONCLUSION: In women with a prior preterm birth, CRH levels were higher and had an earlier rise in women who experienced recurrent preterm birth. Second trimester CRH may be useful in identifying a sub-group of women with preterm birth due to early activation of the placenta-fetal adrenal axis. Assay methodology is a variable that contributes to difficulties in reproducibility of CRH levels in the obstetric literature.
format Online
Article
Text
id pubmed-8445461
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-84454612021-09-17 Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth Herrera, Christina L. Bowman, Maria E. McIntire, Donald D. Nelson, David B. Smith, Roger PLoS One Research Article OBJECTIVE: To determine if maternal plasma CRH and preterm birth history were associated with recurrent preterm birth risk in a high-risk cohort. STUDY DESIGN: Secondary analysis of pregnant women with a prior preterm birth ≤35 weeks receiving 17-alpha hydroxyprogesterone caproate for the prevention of recurrent spontaneous preterm birth. All women with a 24-week blood sample were included. Maternal plasma CRH level at 24- and 32-weeks’ gestation was measured using both enzyme-linked immunosorbent assay (ELISA) and extracted radioimmunoassay (RIA) technologies. The primary outcome was spontaneous preterm birth <37 weeks. The association of CRH, prior preterm birth history, and the two combined was assessed in relation to recurrent preterm birth risk. RESULTS: Recurrent preterm birth in this cohort of 169 women was 24.9%. Comparing women who subsequently delivered <37 versus ≥37 weeks, mean levels of CRH measured by RIA were significantly different at 24 weeks (111.1±87.5 vs. 66.1±45.4 pg/mL, P = .002) and 32 weeks (440.9±275.6 vs. 280.2±214.5 pg/mL, P = .003). The area under the receiver operating curve (AUC) at 24 and 32 weeks for (1) CRH level was 0.68 (95% CI 0.59–0.78) and 0.70 (95% CI 0.59–0.81), (2) prior preterm birth history was 0.75 (95% CI 0.67–0.83) and 0.78 (95% CI 0.69–0.87), and (3) combined was 0.81 (95% CI 0.73–0.88, P = .001) and 0.81 (95% CI 0.72–0.90, P = .01) respectively for delivery <37 weeks. CRH measured by ELISA failed to correlate with gestational age or other clinical parameters. CONCLUSION: In women with a prior preterm birth, CRH levels were higher and had an earlier rise in women who experienced recurrent preterm birth. Second trimester CRH may be useful in identifying a sub-group of women with preterm birth due to early activation of the placenta-fetal adrenal axis. Assay methodology is a variable that contributes to difficulties in reproducibility of CRH levels in the obstetric literature. Public Library of Science 2021-09-16 /pmc/articles/PMC8445461/ /pubmed/34529698 http://dx.doi.org/10.1371/journal.pone.0257422 Text en © 2021 Herrera et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Herrera, Christina L.
Bowman, Maria E.
McIntire, Donald D.
Nelson, David B.
Smith, Roger
Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth
title Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth
title_full Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth
title_fullStr Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth
title_full_unstemmed Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth
title_short Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth
title_sort revisiting the placental clock: early corticotrophin-releasing hormone rise in recurrent preterm birth
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445461/
https://www.ncbi.nlm.nih.gov/pubmed/34529698
http://dx.doi.org/10.1371/journal.pone.0257422
work_keys_str_mv AT herrerachristinal revisitingtheplacentalclockearlycorticotrophinreleasinghormoneriseinrecurrentpretermbirth
AT bowmanmariae revisitingtheplacentalclockearlycorticotrophinreleasinghormoneriseinrecurrentpretermbirth
AT mcintiredonaldd revisitingtheplacentalclockearlycorticotrophinreleasinghormoneriseinrecurrentpretermbirth
AT nelsondavidb revisitingtheplacentalclockearlycorticotrophinreleasinghormoneriseinrecurrentpretermbirth
AT smithroger revisitingtheplacentalclockearlycorticotrophinreleasinghormoneriseinrecurrentpretermbirth